Andrea joined Mérieux Equity Partners in 2023 for a 6-month internship before integrating the team as an Investment Analyst in January 2025.
Prior to this, he served as a Medicinal Chemist Intern at the University of Turin, focusing on the development of selective modulators of glutamate neurotransmission.
Andrea holds a Master's degree in Pharmaceutical Chemistry and Technology from the University of Turin and an MSc in Biopharmaceutical Management from ESCP Business School.
